Freeline Therapeutics Holdings Price on May 3, 2023
FRLNDelisted Stock | USD 4.31 0.28 6.10% |
If you're considering investing in Freeline Stock, it is important to understand the factors that can impact its price. As of today, the current price of Freeline Therapeutics stands at 4.31, as last reported on the 25th of December, with the highest price reaching 4.72 and the lowest price hitting 4.15 during the day. We have found twenty-three technical indicators for Freeline Therapeutics Holdings, which you can use to evaluate the volatility of the firm. Please confirm Freeline Therapeutics' Variance of 108.77, standard deviation of 10.43, and Mean Deviation of 5.9 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
Freeline Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Freeline |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
FRLN |
Based on monthly moving average Freeline Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Freeline Therapeutics by adding Freeline Therapeutics to a well-diversified portfolio.
Freeline Therapeutics Valuation on May 3, 2023
It is possible to determine the worth of Freeline Therapeutics on a given historical date. On May 3, 2023 Freeline was worth 0.33 at the beginning of the trading date compared to the closed value of 4.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Freeline Therapeutics stock. Still, in general, we apply an absolute valuation method to find Freeline Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Freeline Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Freeline Therapeutics' related companies.
Open | High | Low | Close | Volume | |
0.30 | 4.65 | 4.65 | 4.65 | 4,507 | |
05/03/2023 | 0.33 | 4.50 | 4.50 | 4.50 | 8,060 |
0.30 | 4.13 | 4.13 | 4.13 | 2,787 |
Backtest Freeline Therapeutics | | | Freeline Therapeutics History | | | Freeline Therapeutics Valuation | Previous | Next |
Freeline Therapeutics Trading Date Momentum on May 3, 2023
On May 04 2023 Freeline Therapeutics Holdings was traded for 4.13 at the closing time. The top price for the day was 4.13 and the lowest listed price was 4.13 . The trading volume for the day was 2.8 K. The trading history from May 4, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 8.22% . The overall trading delta against the current closing price is 18.89% . |
Freeline Therapeutics Fundamentals Correlations and Trends
By evaluating Freeline Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Freeline Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Freeline financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Freeline Therapeutics Stock history
Freeline Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Freeline is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Freeline Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Freeline Therapeutics stock prices may prove useful in developing a viable investing in Freeline Therapeutics
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom. Freeline Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 235 people.
Freeline Therapeutics Stock Technical Analysis
Freeline Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Freeline Therapeutics Period Price Range
Low | December 25, 2024
| High |
0.00 | 0.00 |
Freeline Therapeutics Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Freeline Therapeutics December 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Freeline Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Freeline Therapeutics shares will generate the highest return on investment. By undertsting and applying Freeline Therapeutics stock market strength indicators, traders can identify Freeline Therapeutics Holdings entry and exit signals to maximize returns
Freeline Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Freeline Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Freeline Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Freeline to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0022 | |||
Jensen Alpha | (0.03) | |||
Total Risk Alpha | (0.55) | |||
Treynor Ratio | 0.0491 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Freeline Stock
If you are still planning to invest in Freeline Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Freeline Therapeutics' history and understand the potential risks before investing.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |